Chefarzt Kardiologie
Prof. Dr. med. Thorsten Lewalter (Kardiologe)
Prof. Dr. med. Thorsten Lewalter
ist Facharzt für Innere Medizin/Kardiologie. Nach Studium in Marburg und Würzburg, Facharztausbildung am Universitätsklinikum Bonn (UKB), dort langjährige Tätigkeit als leitender Oberarzt. 2007 Berufung zum Universitätsprofessor für klinische und experimentelle Elektrophysiologie am UKB. Es folgten Chefarztpositionen in Paderborn, Bonn und München. Er gilt international als renommierter Experte für die Behandlung von Herzrhythmusstörungen und ist Mitherausgeber zahlreicher Fachzeitschriften und Fachbücher. Er etablierte zahlreiche neue Behandlungsverfahren wie z.B. die LASER-Ablation bei Vorhofflimmern und gehört zu den Mitbegründern der modernen Therapie von Herzrhythmusstörungen. Er ist zudem ausgewiesener Experte in allen Verfahren der interventionellen Kardiologie (Herzkatheter) und ProktorAusbilder für neue Behandlungsverfahren in der Medizin für moderne Therapieverfahren (z.B. Vorhoforhverschluss). Seit 2008 lehrt er als außerplanmäßiger Professor am Universitätsklinikum Bonn.
Prof. Lewalter ist ein weltweit angesehener Experte für die Therapie von Herzrhythmusstörungen. Ein besonderer Schwerpunkt ist die Ablation von Vorhofflimmern mit modernsten Verfahren. Er führte die LASER-Ablation im süddeutschen Raum ein und gehört weltweit zu den Anwendern mit der größten Erfahrung für das neue Verfahren. Er verfügt über eine besondere Expertise bei der Therapie komplexer Arrhythmien (Kammertachykardien, WPW etc.).
Schwerpunkte/Expertise
Veröffentlichungen
Zylla MM, Brachmann J, Lewalter T, Hoffmann E, Kuck KH, Andresen D, Willems S, Eckardt L, Tebbenjohanns J, Spitzer SG, Schumacher B, Hochadel M, Senges J, Katus HA, Thomas D.Heart Rhythm. 2016 Jun 8. pii: S1547-5271(16)30382-4. doi: 10.1016/j.hrthm.2016.06.005. [Epub ahead of print]
[How to do: Cardioversion].
Lewalter T, Jilek C.
Dtsch Med Wochenschr. 2016 May;141(10):706-8. doi: 10.1055/s-0042-103304. Epub 2016 May 13. German.
Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints and data collection requirements for clinical studies.
Tzikas A, Holmes DR Jr, Gafoor S, Ruiz CE, Blomström-Lundqvist C, Diener HC, Cappato R, Kar S, Lee RJ, Byrne RA, Ibrahim R, Lakkireddy D, Soliman OI, Näbauer M, Schneider S, Brachman J, Saver JL, Tiemann K, Sievert H, Camm AJ, Lewalter T.
EuroIntervention. 2016 May 17;12(1):103-11. doi: 10.4244/EIJV12I1A18.
Development of radiation exposure in patients undergoing pulmonary vein isolation in Germany between 2007 and 2014: great potential to minimize radiation dosage. Kleemann T, Brachmann J, Lewalter T, Andresen D, Willems S, Spitzer SG, Hoffmann E, Eckardt L, Hochadel M, Senges J, Kuck KH, Seidl K, Zahn R. Clin Res Cardiol. 2016 May 3. [Epub ahead of print]
Left atrial appendage occlusion with the AMPLATZER Amulet device: an expert consensus step-by-step approach. Tzikas A, Gafoor S, Meerkin D, Freixa X, Cruz-Gonzalez I, Lewalter T, Saw J, Berti S, Nielsen-Kudsk JE, Ibrahim R, Lakkireddy D, Paul V, Arzamendi D, Nietlispach F, Worthley SG, Hildick-Smith D, Thambo JB, Tondo C, Aminian A, Kalarus Z, Schmidt B, Sondergaard L, Kefer J, Meier B, Park JW, Sievert H, Omran H. EuroIntervention. 2016 Apr 20;11(13):1512-21. doi: 10.4244/EIJV11I13A292.
[Atrial fibrillation - Update 2016]. Lewalter T. MMW Fortschr Med. 2016 Apr 21;158 Spec No 1:20-6; quiz 27-8. doi: 10.1007/s15006-016-7654-x. German.
[Efficacy and safety of transvenous-implanted wireless pacemakers : LEADLESS II Study]. Lewalter T, Nitschmann S.Internist (Berl). 2016 May;57(5):508-10. doi: 10.1007/s00108-016-0041-y.
Catheter ablation of atrial fibrillation and atrial flutter in patients with diabetes mellitus: Who benefits and who does not? Data from the German ablation registry. Bogossian H, Frommeyer G, Brachmann J, Lewalter T, Hoffmann E, Kuck KH, Andresen D, Willems S, Spitzer SG, Deneke T, Thomas D, Hochadel M, Senges J, Eckardt L, Lemke B. Int J Cardiol. 2016 Jul 1;214:25-30. doi: 10.1016/j.ijcard.2016.03.069. Epub 2016 Mar 24.
Tailored treatment strategies: a new approach for modern management of atrial fibrillation. Van Gelder IC, Hobbelt AH, Marcos EG, Schotten U, Cappato R, Lewalter T, Schwieler J, Rienstra M, Boriani G. J Intern Med. 2016 May;279(5):457-66. doi: 10.1111/joim.12489. Epub 2016 Mar 16.
Catheter ablation of atrial fibrillation in patients with concomitant sinus bradycardia-Insights from the German Ablation Registry. Zylla MM, Brachmann J, Lewalter T, Hoffmann E, Kuck KH, Andresen D, Willems S, Hochadel M, Senges J, Katus HA, Thomas D. J Electrocardiol. 2016 Mar-Apr;49(2):117-23. doi: 10.1016/j.jelectrocard.2015.12.007. Epub 2015 Dec 24.
Impact of Complete Versus Incomplete Circumferential Lines Around the Pulmonary Veins During Catheter Ablation of Paroxysmal Atrial Fibrillation: Results From the Gap-Atrial Fibrillation-German Atrial Fibrillation Competence Network 1 Trial. Kuck KH, Hoffmann BA, Ernst S, Wegscheider K, Treszl A, Metzner A, Eckardt L, Lewalter T, Breithardt G, Willems S; Gap-AF–AFNET 1 Investigators*. Circ Arrhythm Electrophysiol. 2016 Jan;9(1):e003337. doi:
A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference. Kirchhof P, Breithardt G, Bax J, Benninger G, Blomstrom-Lundqvist C, Boriani G, Brandes A, Brown H, Brueckmann M, Calkins H, Calvert M, Christoffels V, Crijns H, Dobrev D, Ellinor P, Fabritz L, Fetsch T, Freedman SB, Gerth A, Goette A, Guasch E, Hack G, Haegeli L, Hatem S, Haeusler KG, Heidbüchel H, Heinrich-Nols J, Hidden-Lucet F, Hindricks G, Juul-Möller S, Kääb S, Kappenberger L, Kespohl S, Kotecha D, Lane DA, Leute A, Lewalter T, Meyer R, Mont L, Münzel F, Nabauer M, Nielsen JC, Oeff M, Oldgren J, Oto A, Piccini JP, Pilmeyer A, Potpara T, Ravens U, Reinecke H, Rostock T, Rustige J, Savelieva I, Schnabel R, Schotten U, Schwichtenberg L, Sinner MF, Steinbeck G, Stoll M, Tavazzi L, Themistoclakis S, Tse HF, Van Gelder IC, Vardas PE, Varpula T, Vincent A, Werring D, Willems S, Ziegler A, Lip GY, Camm AJ. Europace. 2016 Jan;18(1):37-50. doi: 10.1093/europace/euv304. Epub 2015 Oct 18. Review.
[Insertable Cardiac Monitor]. Lewalter T, Koutsouraki I, Brodherr T. Dtsch Med Wochenschr. 2015 Aug;140(17):1286-9. doi: 10.1055/s-0041-103932. Epub 2015 Aug 25. German.
[Differential diagnosis of a narrow QRS tachycardia]. Lewalter T. Herzschrittmacherther Elektrophysiol. 2015 Sep;26(3):200-7. doi: 10.1007/s00399-015-0393-3. Epub 2015 Aug 19. German.
Effects of enhanced pacing modalities on health care resource utilization and costs in bradycardia patients: An analysis of the randomized MINERVA trial. Boriani G, Manolis AS, Tukkie R, Mont L, Pürerfellner H, Santini M, Inama G, Serra P, Gulizia M, Samoilenko IV, Wolff C, Holbrook R, Gavazza F, Padeletti L; MINERVA Investigators. Heart Rhythm. 2015 Jun;12(6):1192-200. doi: 10.1016/j.hrthm.2015.02.017. Epub 2015 Feb 19.
Oral anticoagulation is frequently discontinued after ablation of paroxysmal atrial fibrillation despite previous stroke: data from the German Ablation Registry. Nührich JM, Kuck KH, Andresen D, Steven D, Spitzer SG, Hoffmann E, Schumacher B, Eckardt L, Brachmann J, Lewalter T, Hochadel M, Senges J, Willems S, Hoffmann BA. Clin Res Cardiol. 2015 Jun;104(6):463-70. doi: 10.1007/s00392-014-0804-1. Epub 2014 Dec 24.
Proceedings of the 7th International Symposium on Interventional Electrophysiology. Foreword. Lewalter T, Saksena S. J Interv Card Electrophysiol. 2014 Sep;40(3):207. No abstract available.
[Anticoagulation in high thromboembolic risk after catheter ablation for atrial fibrillation: results from the German Ablation Registry]. Moser J, Kuck KH, Andresen D, Spitzer SG, Hoffmann E, Schumacher B, Eckardt L, Brachmann J, Lewalter T, Hochadel M, Senges J, Willems S, Hoffmann BA. Dtsch Med Wochenschr. 2014 Sep;139(39):1923-8. doi: 10.1055/s-0034-1387316. Epub 2014 Sep 16. German.
Remote monitoring of implantable cardioverter-defibrillators: financial impact for providers and benefits to patients.
Lewalter T, Brodherr T. Eur Heart J. 2015 Jan 14;36(3):143-4. doi: 10.1093/eurheartj/ehu372. Epub 2014 Sep 1. No abstract available.
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion. Meier B, Blaauw Y, Khattab AA, Lewalter T, Sievert H, Tondo C, Glikson M; Document Reviewers. Europace. 2014 Oct;16(10):1397-416. doi: 10.1093/europace/euu174. Epub 2014 Aug 29. No abstract available.
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion. Meier B, Blaauw Y, Khattab AA, Lewalter T, Sievert H, Tondo C, Glikson M. EuroIntervention. 2015 Jan;10(9):1109-25. doi: 10.4244/EIJY14M08_18. Review. No abstract available.
Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Hindricks G, Taborsky M, Glikson M, Heinrich U, Schumacher B, Katz A, Brachmann J, Lewalter T, Goette A, Block M, Kautzner J, Sack S, Husser D, Piorkowski C, Søgaard P; IN-TIME study group. Lancet. 2014 Aug 16;384(9943):583-90. doi: 10.1016/S0140-6736(14)61176-4.
Differences of two cryoballoon generations: insights from the prospective multicentre, multinational FREEZE Cohort Substudy. Straube F, Dorwarth U, Vogt J, Kuniss M, Heinz Kuck K, Tebbenjohanns J, Garcia Alberola A, Chun KR, Souza JJ, Ouarrak T, Senges J, Brachmann J, Lewalter T, Hoffmann E. Europace. 2014 Oct;16(10):1434-42. doi: 10.1093/europace/euu162. Epub 2014 Jul 3.
[Treatment strategies atrial fibrillation]. Lewalter T. MMW Fortschr Med. 2014 Mar 27;156 Spec No 1(1):49-52; quiz 53-4. German. No abstract available.
Ischaemic stroke prevention in patients with atrial fibrillation and high bleeding risk: opportunities and challenges for percutaneous left atrial appendage occlusion. Lewalter T, Kanagaratnam P, Schmidt B, Rosenqvist M, Nielsen-Kudsk JE, Ibrahim R, Albers BA, Camm AJ. Europace. 2014 May;16(5):626-30. doi: 10.1093/europace/euu069. Review.
Contemporary real life cardioversion of atrial fibrillation: Results from the multinational RHYTHM-AF study. Crijns HJ, Weijs B, Fairley AM, Lewalter T, Maggioni AP, Martín A, Ponikowski P, Rosenqvist M, Sanders P, Scanavacca M, Bash LD, Chazelle F, Bernhardt A, Gitt AK, Lip GY, Le Heuzey JY. Int J Cardiol. 2014 Apr 1;172(3):588-94. doi: 10.1016/j.ijcard.2014.01.099. Epub 2014 Jan 25.
[Radiofrequency ablation for paroxysmal atrial fibrillation : Medical antiarrhythmic treatment or radiofrequency ablation in paroxysmal atrial fibrillation (MANTRA-PAF trial)]. Lewalter T, Nitschmann S. Internist (Berl). 2014 Mar;55(3):340-1. doi: 10.1007/s00108-014-3455-4. German. No abstract available.
The atrial fibrillation ablation pilot study: a European Survey on Methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm Association. Arbelo E, Brugada J, Hindricks G, Maggioni AP, Tavazzi L, Vardas P, Laroche C, Anselme F, Inama G, Jais P, Kalarus Z, Kautzner J, Lewalter T, Mairesse GH, Perez-Villacastin J, Riahi S, Taborsky M, Theodorakis G, Trines SA; Atrial Fibrillation Ablation Pilot Study Investigators. Eur Heart J. 2014 Jun 7;35(22):1466-78. doi: 10.1093/eurheartj/ehu001. Epub 2014 Jan 31.
Remote monitoring of cardiac implantable electronic devices in Europe: results of the European Heart Rhythm Association survey. Hernández-Madrid A, Lewalter T, Proclemer A, Pison L, Lip GY, Blomstrom-Lundqvist C; Scientific Initiatives Committee, European Heart Rhythm Association. Europace. 2014 Jan;16(1):129-32. doi: 10.1093/europace/eut414.
Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices). Boriani G, Glotzer TV, Santini M, West TM, De Melis M, Sepsi M, Gasparini M, Lewalter T, Camm JA, Singer DE.Eur Heart J. 2014 Feb;35(8):508-16. doi: 10.1093/eurheartj/eht491. Epub 2013 Dec 11.
Cryoballoon versus RF ablation in paroxysmal atrial fibrillation: results from the German Ablation Registry. Schmidt M, Dorwarth U, Andresen D, Brachmann J, Kuck KH, Kuniss M, Lewalter T, Spitzer S, Willems S, Senges J, Jünger C, Hoffmann E. J Cardiovasc Electrophysiol. 2014 Jan;25(1):1-7. doi:
Heart failure in patients with atrial fibrillation is associated with a high symptom and hospitalization burden: the RealiseAF survey. Silva-Cardoso J, Zharinov OJ, Ponikowski P, Naditch-Brûlé L, Lewalter T, Brette S, Steg PG; RealiseAF Investigators. Clin Cardiol. 2013 Dec;36(12):766-74. doi: 10.1002/clc.22209. Epub 2013 Sep 17.
Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey. Lip GY, Bongiorni MG, Dobreanu D, Lewalter T, Hastrup Svendsen J, Blomström-Lundqvist C; Scientific Initiative Committee, European Heart Rhythm Association. Europace. 2013 Oct;15(10):1526-32. doi: 10.1093/europace/eut292.
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. Kirchhof P, Breithardt G, Aliot E, Al Khatib S, Apostolakis S, Auricchio A, Bailleul C, Bax J, Benninger G, Blomstrom-Lundqvist C, Boersma L, Boriani G, Brandes A, Brown H, Brueckmann M, Calkins H, Casadei B, Clemens A, Crijns H, Derwand R, Dobrev D, Ezekowitz M, Fetsch T, Gerth A, Gillis A, Gulizia M, Hack G, Haegeli L, Hatem S, Häusler KG, Heidbüchel H, Hernandez-Brichis J, Jais P, Kappenberger L, Kautzner J, Kim S, Kuck KH, Lane D, Leute A, Lewalter T, Meyer R, Mont L, Moses G, Mueller M, Münzel F, Näbauer M, Nielsen JC, Oeff M, Oto A, Pieske B, Pisters R, Potpara T, Rasmussen L, Ravens U, Reiffel J, Richard-Lordereau I, Schäfer H, Schotten U, Stegink W, Stein K, Steinbeck G, Szumowski L, Tavazzi L, Themistoclakis S, Thomitzek K, Van Gelder IC, von Stritzky B, Vincent A, Werring D, Willems S, Lip GY, Camm AJ. Europace. 2013 Nov;15(11):1540-56. doi: 10.1093/europace/eut232. Epub 2013 Aug 27.
Current practice for diagnosis and management of silent atrial fibrillation: results of the European Heart Rhythm Association survey. Dobreanu D, Svendsen JH, Lewalter T, Hernández-Madrid A, Lip GY, Blomström-Lundqvist C; Scientific Initiatives Committee, European Heart Rhythm Association. Europace. 2013 Aug;15(8):1223-5. doi: 10.1093/europace/eut227.
Types and outcomes of cardioversion in patients admitted to hospital for atrial fibrillation: results of the German RHYTHM-AF Study. Gitt AK, Smolka W, Michailov G, Bernhardt A, Pittrow D, Lewalter T. Clin Res Cardiol. 2013 Oct;102(10):713-23. doi: 10.1007/s00392-013-0586-x. Epub 2013 Jun 30.
Screening and risk evaluation for sudden cardiac death in ischaemic and non-ischaemic cardiomyopathy: results of the European Heart Rhythm Association survey. Proclemer A, Lewalter T, Bongiorni MG, Svendsen JH, Pison L, Lundqvist CB; Scientific Initiative Committee, European Heart Rhythm Association. Europace. 2013 Jul;15(7):1059-62. doi: 10.1093/europace/eut187. Erratum in: Europace. 2013 Nov;15(11):1684. Nielsen, Jesper Hastrup [corrected to Svendsen, Jesper Hastrup].
Left atrial pressure as predictor for recurrence of atrial fibrillation after pulmonary vein isolation. Linhart M, Lewalter T, Mittmann-Braun EL, Karbach NC, Andrié RP, Hammerstingl C, Fimmers R, Kreuz J, Nickenig G, Schrickel JW, Lickfett LM. J Interv Card Electrophysiol. 2013 Nov;38(2):107-14. doi: 10.1007/s10840-013-9803-9. Epub 2013 Jun 23.
Cardioversion for atrial fibrillation in current European practice: results of the European Heart Rhythm Association survey. Hernández-Madrid A, Svendsen JH, Lip GY, Van Gelder IC, Dobreanu D, Blomstrom-Lundqvist C; Scientific Initiatives Committee, European Heart Rhythm Association (EHRA). Europace. 2013 Jun;15(6):915-8. doi: 10.1093/europace/eut143.
Chloroquine cardiomyopathy - a review of the literature. Tönnesmann E, Kandolf R, Lewalter T. Immunopharmacol Immunotoxicol. 2013 Jun;35(3):434-42. doi: 10.3109/08923973.2013.780078. Epub 2013 May 1. Review.
Current strategy for treatment of patients with Wolff-Parkinson-White syndrome and asymptomatic preexcitation in Europe: European Heart Rhythm Association survey. Svendsen JH, Dagres N, Dobreanu D, Bongiorni MG, Marinskis G, Blomström-Lundqvist C; Scientific Initiatives Committee, European Heart Rhythm Association. Europace. 2013 May;15(5):750-3. doi: 10.1093/europace/eut094.
An update and current expert opinions on percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation. Lewalter T, Ibrahim R, Albers B, Camm AJ. Europace. 2013 May;15(5):652-6. doi: 10.1093/europace/eut043.
[Implantable cardioverter defibrillator]. Stellbrink C, Andresen D, Böcker D, Lewalter T. Herzschrittmacherther Elektrophysiol. 2013 Mar;24(1):75-8. doi: 10.1007/s00399-013-0265-7. Review. German.
Potential role of telemedical service centers in managing remote monitoring data transmitted daily by cardiac implantable electronic devices: results of the early detection of cardiovascular events in device patients with heart failure (detecT-Pilot) study. Müller A, Goette A, Perings C, Nägele H, Konorza T, Spitzer W, Schulz SS, von Bary C, Hoffmann M, Albani M, Sack S, Niederlöhner A, Lewalter T. Telemed J E Health. 2013 Jun;19(6):460-6. doi:
Current practice of antiarrhythmic drug therapy for prevention of atrial fibrillation in Europe: The European Heart Rhythm Association survey. Dagres N, Lewalter T, Lip GY, Pison L, Proclemer A, Blomström-Lundqvist C; Scientific Initiatives Committee, European Heart Rhythm Association. Europace. 2013 Apr;15(4):478-81. doi: 10.1093/europace/eut063.
X-ray exposure hazards for physicians performing ablation procedures and device implantation: results of the European Heart Rhythm Association survey. Marinskis G, Bongiorni MG, Dagres N, Lewalter T, Pison L, Blomstrom-Lundqvist C; Scientific Initiative Committee, European Heart Rhythm Association. Europace. 2013 Mar;15(3):444-6. doi: 10.1093/europace/eut022. Epub 2013 Feb 6.
Differences in clinical and echocardiographic parameters between paroxysmal and persistent atrial flutter in the AURUM 8 study: targets for prevention of persistent arrhythmia? Lickfett L, Mittmann-Braun E, Weiss C, Spencker S, Jung W, Haverkamp W, Willems S, Deneke T, Kautzner J, Wiedemann M, Siebels J, Pitschner HF, Hoffmann E, Hindricks G, Zabel M, Vester E, Schwacke H, Leyen JV, Mewis C, Bauer W, Lewalter T. Pacing Clin Electrophysiol. 2013 Feb;36(2):194-202. doi: 10.1111/pace.12051.
Current practice in Europe: how do we manage patients with ventricular tachycardia? European Heart Rhythm Association survey. Proclemer A, Dagres N, Marinskis G, Pison L, Lip GY, Blomstrom-Lundqvist C; Scientific Initiative Committee, European Heart Rhythm Association. Europace. 2013 Feb;15(2):167-9. doi: 10.1093/europace/eus436.
Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: results of the European Heart Rhythm Association survey. Lip GY, Dagres N, Proclemer A, Svendsen JH, Pison L, Blomstrom-Lundqvist C; Scientific Initiative Committee, European Heart Rhythm Association. Europace. 2013 Jan;15(1):141-3. doi: 10.1093/europace/eus413.
Performing magnetic resonance imaging in patients with implantable pacemakers and defibrillators: results of a European Heart Rhythm Association survey. Marinskis G, Bongiorni MG, Dagres N, Dobreanu D, Lewalter T, Blomström-Lundqvist C; Scientific Initiative Committee, European Heart Rhythm Association. Europace. 2012 Dec;14(12):1807-9. doi: 10.1093/europace/eus379. Epub 2012 Nov 6.
How European centres diagnose, treat, and prevent CIED infections: results of an European Heart Rhythm Association survey. Bongiorni MG, Marinskis G, Lip GY, Svendsen JH, Dobreanu D, Blomström-Lundqvist C; Scientific Initiative Committee, European Heart Rhythm Association. Europace. 2012 Nov;14(11):1666-9. doi: 10.1093/europace/eus350.
RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers. Crijns HJ, Bash LD, Chazelle F, Le Heuzey JY, Lewalter T, Lip GY, Maggioni AP, Martín A, Ponikowski P, Rosenqvist M, Sanders P, Scanavacca M, Bernhardt AA, Unniachan S, Phatak HM, Gitt AK. BMC Cardiovasc Disord. 2012 Oct 2;12:85. doi: 10.1186/1471-2261-12-85.
Atrial fibrillation ablation techniques. Lewalter T, Dobreanu D, Proclemer A, Marinskis G, Pison L, Blomström-Lundqvist C; Scientific Initiative Committee-European Heart Rhythm Association. Europace. 2012 Oct;14(10):1515-7.
Cardiomyocyte-specific deletion of survivin causes global cardiac conduction defects. Schrickel JW, Lickfett L, Lewalter T, Tiemann K, Nickenig G, Baba H, Heusch G, Schulz R, Levkau B. Basic Res Cardiol. 2012 Nov;107(6):299. doi: 10.1007/s00395-012-0299-8. Epub 2012 Sep 14.
Relevance of Monitoring Atrial Fibrillation in Clinical Practice. Lewalter T, Boriani G. Arrhythm Electrophysiol Rev. 2012 Sep;1(1):54-8. doi: 10.15420/aer.2012.1.1.54.
Three-dimensional guided renal denervation to treat drug-resistant arterial hypertension in a patient with renal insufficiency. Lewalter T, Brodherr T. Hypertension. 2012 Oct;60(4):e33. doi: 10.1161/HYPERTENSIONAHA.112.201467. Epub 2012 Aug 20. No abstract available.
Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry. Chiang CE, Naditch-Brûlé L, Murin J, Goethals M, Inoue H, O'Neill J, Silva-Cardoso J, Zharinov O, Gamra H, Alam S, Ponikowski P, Lewalter T, Rosenqvist M, Steg PG. Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):632-9.doi:0.1161/CIRCEP.112.970749. Epub 2012 Jul 11.
Surgical and hybrid atrial fibrillation ablation procedures. Pison L, Dagres N, Lewalter T, Proclemer A, Marinskis G, Blomström-Lundqvist C; Scientific Initiative Committee, European Heart Rhythm Association. Europace. 2012 Jul;14(7):939-41. doi: 10.1093/europace/eus207.
ESC-EURObservational Research Programme: the Atrial Fibrillation Ablation Pilot Study, conducted by the European Heart Rhythm Association. Arbelo E, Brugada J, Hindricks G, Maggioni A, Tavazzi L, Vardas P, Anselme F, Inama G, Jais P, Kalarus Z, Kautzner J, Lewalter T, Mairesse G, Perez-Villacastin J, Riahi S, Taborsky M, Theodorakis G, Trines S; Atrial Fibrillation Ablation Pilot Study Investigators. Europace. 2012 Aug;14(8):1094-103. Epub 2012 May 24.
[Rhythm---control in atrial fibrillation]. Lewalter T. MMW Fortschr Med. 2012 Mar 22;154(5):55-7. German. No abstract available.
[Prophylaxis of stroke and embolisms in atrial fibrillation--what is new in the guidelines?]. Lewalter T. MMW Fortschr Med. 2012 Mar 22;154(5):50-2, 54. Review. German. No abstract available.
[Innovations in therapy of atrial fibrillation]. Lewalter T. MMW Fortschr Med. 2012 Mar 22;154(5):49. German. No abstract available.
Adverse effects of permanent atrial fibrillation on heart failure in patients with preserved left ventricular function and chronic right apical pacing for complete heart block. Lampe B, Hammerstingl C, Schwab JO, Mellert F, Stoffel-Wagner B, Grigull A, Fimmers R, Maisch B, Nickenig G, Lewalter T, Yang A. Clin Res Cardiol. 2012 Oct;101(10):829-36. Epub 2012 May 16.
[Catheter ablation in patients with atrial fibrillation]. Lewalter T. MMW Fortschr Med. 2012 Apr 19;154(7):92-4. Review. German. No abstract available.
Cardiomyopathy caused by longterm treatment with chloroquine: a rare disease, or a rare diagnosis? Tönnesmann E, Stroehmann I, Kandolf R, Wolburg H, Strach K, Musshoff F, Tiemann K, Lewalter T. J Rheumatol. 2012 May;39(5):1099-103. doi: 10.3899/jrheum.110959. No abstract available.
Periprocedural anticoagulation therapy for devices and atrial fibrillation ablation. Lip GY, Proclemer A, Dagres N, Bongiorni MG, Lewalter T, Blomström-Lundqvist C; Scientific Initiative Committee, European Heart Rhythm Association. Europace. 2012 May;14(5):741-4. doi: 10.1093/europace/eus105.
"Largest amplitude ablation" is the optimal approach for typical atrial flutter ablation: a subanalysis from the AURUM 8 study. Lewalter T, Lickfett L, Weiss C, Mewis C, Spencker S, Jung W, Haverkamp W, Schwacke H, Deneke T, Proff J, Dorwarth U, Bauer W. J Cardiovasc Electrophysiol. 2012 May;23(5):479-85. doi: 10.1111/j.1540-8167.2011.02252.x. Epub 2012 Mar 27.
Monitoring in the management of atrial fibrillation. Lewalter T, Morgan J, Halimi F, Lip G, Dagres N, Blomström-Lundqvist C; Scientific Initiative Committee, European Heart Rhythm Association. Europace. 2012 Apr;14(4):591-2. doi: 10.1093/europace/eus073.
Practices of cardiac implantable electronic device follow-up: results of the European Heart Rhythm Association survey. Marinskis G, van Erven L, Bongiorni MG, Lip GY, Pison L, Blomström-Lundqvist C; Scientific Initiative Committee, European Heart Rhythm Association. Europace. 2012 Mar;14(3):423-5. doi: 10.1093/europace/eus020.
Outpatient evaluation and management of patients with ventricular premature beats or non-sustained ventricular tachycardia. Svendsen JH, Goette A, Dobreanu D, Marinskis G, Mabo P, Blomström-Lundqvist C; Scientific Initiative Committee, European Heart Rhythm Association. Europace. 2012 Feb;14(2):294-6. doi: 10.1093/europace/eus009.
Current practice of ventricular tachycardia ablation in patients with implantable cardioverter-defibrillators. Dagres N, Cantù F, Geelen P, Lewalter T, Proclemer A, Blomström-Lundqvist C. Europace. 2012 Jan;14(1):135-7. doi: 10.1093/europace/eur411.
Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: data from the RealiseAF cross-sectional international registry. Steg PG, Alam S, Chiang CE, Gamra H, Goethals M, Inoue H, Krapf L, Lewalter T, Merioua I, Murin J, Naditch-Brûlé L, Ponikowski P, Rosenqvist M, Silva-Cardoso J, Zharinov O, Brette S, Neill JO; RealiseAF investigators. Heart. 2012 Feb;98(3):195-201. doi: 10.1136/heartjnl-2011-300550. Epub 2011 Sep 22.
[European guidelines on myocardial revascularization]. Perings SM, Bosch R, Eggeling T, Hennersdorf M, Graf La Rosee K, Korte T, Lauer T, Leschke M, Lewalter T, Mathey D, Mudra H, Reifert N, Rybak K, Sievert H, Tiefenbacher C. Herz. 2011 May;36(3):265-6. doi: 10.1007/s00059-011-3465-0. German. No abstract available.
Twenty years of interventional cardiac electrophysiology: Meeting future challenges with continuing innovations. Saksena S, Lewalter T, Luderitz B. J Interv Card Electrophysiol. 2011 Jun;31(1):1-2. doi: 10.1007/s10840-011-9577-x. No abstract available.
Impact of the type of centre on management of AF patients: surprising evidence for differences in antithrombotic therapy decisions. Kirchhof P, Nabauer M, Gerth A, Limbourg T, Lewalter T, Goette A, Wegscheider K, Treszl A, Meinertz T, Oeff M, Ravens U, Breithardt G, Steinbeck G; AFNET registry investigators. Thromb Haemost. 2011 Jun;105(6):1010-23. doi: 10.1160/TH11-02-0070. Epub 2011 May 5.
Spectrum of cardiovascular findings during pregnancy and parturition at a tertiary referral center. Merz WM, Keyver-Paik MD, Baumgarten G, Lewalter T, Gembruch U. J Perinat Med. 2011 May;39(3):251-6. doi: 10.1515/JPM.2011.008. Epub 2011 Apr 19.
[Pulse control in atrial fibrillation: RACE II study]. Lewalter T, Nitschmann S. Internist (Berl). 2011 Jan;52(1):99-100. doi: 10.1007/s00108-010-2749-4. German. No abstract available.
Gold vs. platinum-iridium tip catheter for cavotricuspid isthmus ablation: the AURUM 8 study. Lewalter T, Weiss C, Spencker S, Jung W, Haverkamp W, Willems S, Deneke T, Kautzner J, Wiedemann M, Siebels J, Pitschner HF, Hoffmann E, Hindricks G, Zabel M, Vester E, Schwacke H, Mittmann-Braun E, Lickfett L, Hoffmeister S, Proff J, Mewis C, Bauer W; AURUM 8 Study Investigators. Europace. 2011 Jan;13(1):102-8. doi: 10.1093/europace/euq339. Epub 2010 Sep 28.
Usage patterns and 1-year outcomes with the TAXUS Liberté stent: results of the TAXUS OLYMPIA registry. Ahmed WH, Mendiz OA, Thomas MR; TAXUS OLYMPIA Participating Physicians. Catheter Cardiovasc Interv. 2011 Jun 1;77(7):979-92. doi: 10.1002/ccd.22805. Epub 2010 Dec 3.
Cardiac conduction disturbances and differential effects on atrial and ventricular electrophysiological properties in desmin deficient mice. Schrickel JW, Stöckigt F, Krzyzak W, Paulin D, Li Z, Lübkemeier I, Fleischmann B, Sasse P, Linhart M, Lewalter T, Nickenig G, Lickfett L, Schröder R, Clemen CS. J Interv Card Electrophysiol. 2010 Aug;28(2):71-80. doi: 10.1007/s10840-010-9482-8.
[Atrial fibrillation: drug, interventional or surgical treatment? For drug treatment]. Lewalter T. Dtsch Med Wochenschr. 2010 Apr;135(13):612. doi: 10.1055/s-0030-1251898. Epub 2010 Mar 23. German. No abstract available.
Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Rudolph V, Andrié RP, Rudolph TK, Friedrichs K, Klinke A, Hirsch-Hoffmann B, Schwoerer AP, Lau D, Fu X, Klingel K, Sydow K, Didié M, Seniuk A, von Leitner EC, Szoecs K, Schrickel JW, Treede H, Wenzel U, Lewalter T, Nickenig G, Zimmermann WH, Meinertz T, Böger RH, Reichenspurner H, Freeman BA, Eschenhagen T, Ehmke H, Hazen SL, Willems S, Baldus S. Nat Med. 2010 Apr;16(4):470-4. doi: 10.1038/nm.2124. Epub 2010 Mar 21.
[Clinical pharmacology and electrophysiological properties of dronedarone]. Lewalter T, Pittrow D, Goette A, Kirch W, Hohnloser S. Dtsch Med Wochenschr. 2010 Mar;135 Suppl 2:S43-7. doi: 10.1055/s-0030-1249208. Epub 2010 Mar 10. Review. German.
[Clinical profile of the new antiarrhythmic drug dronedarone]. Schmitt J, Lewalter T, Pittrow D, Duray G, Goette A, Brachmann J, Hohnloser SH. Dtsch Med Wochenschr. 2010 Mar;135 Suppl 2:S38-42. doi: 10.1055/s-0030-1249207. Epub 2010 Mar 10. Review. German.
Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation. Lewalter T. J Am Coll Cardiol. 2010 Mar 9;55(10):1051-2; author reply 1052-3. doi: 10.1016/j.jacc.2009.10.037. No abstract available.
The feasibility of fully automated pacemaker advise in treating atrial tachyarrhythmias. Ruiter JH, Mulder E, Schuchert A, Burri H, Stühlinger MC, Hartikainen J, Sermasi S, Vlasínová J, Mairesse GH, Bub E, Lewalter T; T-STAR Study Group. Pacing Clin Electrophysiol. 2010 May;33(5):605-14. doi: 10.1111/j.1540-8159.2010.02689.x. Epub 2010 Feb 1.
Incidence and predictors of silent cerebral embolism during pulmonary vein catheter ablation for atrial fibrillation. Schrickel JW, Lickfett L, Lewalter T, Mittman-Braun E, Selbach S, Strach K, Nähle CP, Schwab JO, Linhart M, Andrié R, Nickenig G, Sommer T. Europace. 2010 Jan;12(1):52-7. doi: 10.1093/europace/eup350. Epub .
Lack of gelsolin promotes perpetuation of atrial fibrillation in the mouse heart. Schrickel JW, Fink K, Meyer R, Grohé C, Stoeckigt F, Tiemann K, Ghanem A, Lickfett L, Nickenig G, Lewalter T. J Interv Card Electrophysiol. 2009 Oct;26(1):3-10. doi: 10.1007/s10840-009-9425-4. Epub 2009 Aug 8.
[New onset of atrial fibrillation--rate or rhythm control?]. Lewalter T. MMW Fortschr Med. 2009 Apr 16;151(16):29, 31-2. German. No abstract available.
Comparison of cryoballoon and radiofrequency ablation of pulmonary veins in 40 patients with paroxysmal atrial fibrillation: a case-control study. Linhart M, Bellmann B, Mittmann-Braun E, Schrickel JW, Bitzen A, Andrié R, Yang A, Nickenig G, Lickfett L, Lewalter T. J Cardiovasc Electrophysiol. 2009 Dec;20(12):1343-8. doi: 10.1111/j.1540-8167.2009.01560.x. Epub .
[Diagnostic approach in complex arrhythmias]. Lewalter T. Herzschrittmacherther Elektrophysiol. 2009 Apr;20(1):23-32. doi: 10.1007/s00399-009-0027-8. Epub 2009 Apr 18. Review. German.
Dual-chamber implantable cardioverter defibrillators reduce clinical adverse events related to atrial fibrillation when compared with single-chamber defibrillators: a subanalysis of the DATAS trial. Ricci RP, Quesada A, Almendral J, Arribas F, Wolpert C, Adragao P, Zoni-Berisso M, Navarro X, DeSanto T, Grammatico A, Santini M; DATAS study Investigators. Europace. 2009 May;11(5):587-93. doi: 10.1093/europace/eup072.
Early versus delayed, provisional eptifibatide in acute coronary syndromes. Giugliano RP, White JA, Bode C, Armstrong PW, Montalescot G, Lewis BS, van 't Hof A, Berdan LG, Lee KL, Strony JT, Hildemann S, Veltri E, Van de Werf F, Braunwald E, Harrington RA, Califf RM, Newby LK; EARLY ACS Investigators. N Engl J Med. 2009 May 21;360(21):2176-90. doi: 10.1056/NEJMoa0901316. Epub 2009 Mar 30.
In vitro comparison of platinum-iridium and gold tip electrodes: lesion depth in 4 mm, 8 mm, and irrigated-tip radiofrequency ablation catheters. Linhart M, Mollnau H, Bitzen A, Wurtz S, Schrickel JW, Andrié R, Stöckigt F, Weiss C, Nickenig G, Lickfett LM, Lewalter T. Europace. 2009 May;11(5):565-70. doi: 10.1093/europace/eup040. Epub 2009 Feb 26.
Normal impulse propagation in the atrioventricular conduction system of Cx30.2/Cx40 double deficient mice. Schrickel JW, Kreuzberg MM, Ghanem A, Kim JS, Linhart M, Andrié R, Tiemann K, Nickenig G, Lewalter T, Willecke K. J Mol Cell Cardiol. 2009 May;46(5):644-52. doi: 10.1016/j.yjmcc.2009.02.012. Epub 2009 Feb 24.
The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Nabauer M, Gerth A, Limbourg T, Schneider S, Oeff M, Kirchhof P, Goette A, Lewalter T, Ravens U, Meinertz T, Breithardt G, Steinbeck G. Europace. 2009 Apr;11(4):423-34. doi: 10.1093/europace/eun369. Epub 2009 Jan 18.
[Therapeutic aims for atrial fibrillation in patients with heart failure]. Lewalter T, Nitschmann S. Internist (Berl). 2009 Jan;50(1):101-3. doi: 10.1007/s00108-008-2299-1. German. No abstract available.
[The patient with unclear palpitations: how extensive should the diagnostic approach be?]. Lewalter T. Herzschrittmacherther Elektrophysiol. 2008 Sep;19(3):155-9. doi: 10.1007/s00399-008-0018-1. Epub 2008 Oct 25. German.
[What to do in the case of newly-occurring atrial fibrillation?]. Lewalter T. Dtsch Med Wochenschr. 2008 Oct;133(40):2033-6. doi: 10.1055/s-0028-1085617. Epub 2008 Sep 25. Review. German. No abstract available.
Influence of Home Monitoring on the clinical status of heart failure patients: Design and rationale of the IN-TIME study. Arya A, Block M, Kautzner J, Lewalter T, Mörtel H, Sack S, Schumacher B, Søgaard P, Taborsky M, Husser D, Hindricks G; IN-TIME investigators. Eur J Heart Fail. 2008 Nov;10(11):1143-8. doi: 10.1016/j.ejheart.2008.08.004. Epub 2008 Sep 19.
Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial. Almendral J, Arribas F, Wolpert C, Ricci R, Adragao P, Cobo E, Navarro X, Quesada A; DATAS Steering Committee; DATAS Writing Committee; DATAS Investigators. Europace. 2008 May;10(5):528-35. doi: 10.1093/europace/eun072. Epub 2008 Apr 7.
Advanced mapping techniques in atrial fibrillation. Lickfett L, Schwab JO, Lewalter T. J Interv Card Electrophysiol. 2008 Aug;22(2):155-9. doi: 10.1007/s10840-008-9245-y. Epub 2008 Apr 2. Review.
Recovery from ultra-high dose organophosphate poisoning after "in-the-field" antidote treatment: potential lessons for civil defense. Schrickel JW, Lewalter T, Lüderitz B, Nickenig G, Klehr HU, Rabe C. J Emerg Med. 2009 Oct;37(3):279-82. doi: 10.1016/j.jemermed.2007.11.006. Epub 2008 Feb 20.
Morphology-enhanced atrial event classification improves sensing in pacemakers. Lewalter T, Tuininga Y, Fröhlig G, Remerie S, Eberhardt F, Schmidt J, van Groeningen C, Wohlgemuth P. Pacing Clin Electrophysiol. 2007 Dec;30(12):1455-63.
Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Roell W, Lewalter T, Sasse P, Tallini YN, Choi BR, Breitbach M, Doran R, Becher UM, Hwang SM, Bostani T, von Maltzahn J, Hofmann A, Reining S, Eiberger B, Gabris B, Pfeifer A, Welz A, Willecke K, Salama G, Schrickel JW, Kotlikoff MI, Fleischmann BK. Nature. 2007 Dec 6;450(7171):819-24.
Conventional and dedicated atrial overdrive pacing for the prevention of paroxysmal atrial fibrillation: the AFTherapy study. Camm AJ, Sulke N, Edvardsson N, Ritter P, Albers BA, Ruiter JH, Lewalter T, Capucci PA, Hoffmann E; AFTherapy Investigators. Europace. 2007 Dec;9(12):1110-8.
The conditional connexin43G138R mouse mutant represents a new model of hereditary oculodentodigital dysplasia in humans. Dobrowolski R, Sasse P, Schrickel JW, Watkins M, Kim JS, Rackauskas M, Troatz C, Ghanem A, Tiemann K, Degen J, Bukauskas FF, Civitelli R, Lewalter T, Fleischmann BK, Willecke K. Hum Mol Genet. 2008 Feb 15;17(4):539-54. Epub 2007 Nov 13.
Automatic p wave analysis over 24 hours in patients with paroxysmal or persistent atrial fibrillation. Bitzen A, Sternickel K, Lewalter T, Schwab JO, Yang A, Schrickel JW, Linhart M, Wolpert C, Jung W, David P, Lüderitz B, Nickenig G, Lickfett L. Ann Noninvasive Electrocardiol. 2007 Oct;12(4):306-15.
Common trunk of the right and left inferior pulmonary veins: previously unreported anatomic variant with implications for catheter ablation. Lickfett L, Lewalter T, Nickenig G, Naehle P. Heart Rhythm. 2007 Sep;4(9):1244-5. Epub 2007 Feb 20. No abstract available.
Heart failure and malignant ventricular tachyarrhythmias due to hereditary hemochromatosis with iron overload cardiomyopathy. Demant AW, Schmiedel A, Büttner R, Lewalter T, Reichel C. Clin Res Cardiol. 2007 Dec;96(12):900-3. Epub 2007 Aug 20. No abstract available.
Enhanced heterogeneity of myocardial conduction and severe cardiac electrical instability in annexin A7-deficient mice. Schrickel JW, Brixius K, Herr C, Clemen CS, Sasse P, Reetz K, Grohé C, Meyer R, Tiemann K, Schröder R, Bloch W, Nickenig G, Fleischmann BK, Noegel AA, Schwinger RH, Lewalter T. Cardiovasc Res. 2007 Nov 1;76(2):257-68. Epub 2007 Jul 6.
Significance of Wedensky Modulation testing in the evaluation of non-invasive risk stratification for ventricular tachyarrhythmia in patients with coronary artery disease and implantable cardioverter-defibrillator. Elgarhi N, Kreuz J, Balta O, Nickenig G, Hoium H, Lewalter T, Schwab JO. Heart. 2008 Apr;94(4):e16. Epub 2007 Jul 16.
Replacement of connexin43 by connexin26 in transgenic mice leads to dysfunctional reproductive organs and slowed ventricular conduction in the heart. Winterhager E, Pielensticker N, Freyer J, Ghanem A, Schrickel JW, Kim JS, Behr R, Grümmer R, Maass K, Urschel S, Lewalter T, Tiemann K, Simoni M, Willecke K. BMC Dev Biol. 2007 Apr 4;7:26.
Role of high frequency atrial pacing for the termination of acute atrial fibrillation and atypical atrial flutter. Shlevkov N, Yang A, Schrickel JW, Schwab JO, Bielik H, Lickfett L, Bitzen A, Nickenig G, Lüderitz B, Lewalter T. Pacing Clin Electrophysiol. 2007 Mar;30(3):322-32.
Echocardiographic assessment of left ventricular mass in neonatal and adult mice: accuracy of different echocardiographic methods. Ghanem A, Röll W, Hashemi T, Dewald O, Djoufack PC, Fink KB, Schrickel J, Lewalter T, Lüderitz B, Tiemann K. Echocardiography. 2006 Nov;23(10):900-7.
[Ventricular tachycardia. Diagnostic spectrum and therapeutic measures]. Lewalter T, Schwab JO, Nickenig G. Internist (Berl). 2006 Oct;47(10):1001-4, 1006-8, 1010-2. Review. German.
[Epidemiology of atrial fibrillation and relevance of underlying cardiovascular disease]. Lewalter T. Dtsch Med Wochenschr. 2006 Aug 25;131(34-35 Suppl 4):S99-102. Review. German. No abstract available.
Cardiac morphogenetic defects and conduction abnormalities in mice homozygously deficient for connexin40 and heterozygously deficient for connexin45. Krüger O, Maxeiner S, Kim JS, van Rijen HV, de Bakker JM, Eckardt D, Tiemann K, Lewalter T, Ghanem A, Lüderitz B, Willecke K. J Mol Cell Cardiol. 2006 Nov;41(5):787-97. Epub 2006 Aug 17.
[German Competence Network on Atrial Fibrillation (AFNET). A nationwide cooperation for better research and patient care]. Leute A, Kirchhof P, Breithardt G, Goette A, Lewalter T, Meinertz T, Oeff M, Ravens U, Steinbeck G, Weiss T. Med Klin (Munich). 2006 Aug 15;101(8):662-6. German.
Persistence of iatrogenic atrial septal defect after pulmonary vein isolation--an underestimated risk? Hammerstingl C, Lickfett L, Jeong KM, Troatz C, Wedekind JA, Tiemann K, Lüderitz B, Lewalter T. Am Heart J. 2006 Aug;152(2):362.e1-5.
[Electrical and pharmacological strategies for early cardioversion of atrial fibrillation]. Linhart M, Lewalter T. Herzschrittmacherther Elektrophysiol. 2006 Jun;17(2):81-8. Review. German.
Paroxysmal atrial flutter caused by cardiac lymphoma. Linhart M, Lickfett L, Hammerstingl C, Tiemann K, Nickenig G, Lewalter T. Pacing Clin Electrophysiol. 2006 Jun;29(6):682-4.
Identification of "substrate fibrillators" and "trigger fibrillators" by pacemaker diagnostics. Yang A, Ruiter J, Pfeiffer D, Esmailzadeh B, Welz A, Hochhäusler M, Nickenig G, Lüderitz B, Lewalter T. Heart Rhythm. 2006 Jun;3(6):682-8. Epub 2006 Feb 28.
Pro-arrhythmic effects of amiodarone and concomitant rate-control medication. Schrickel JW, Schwab JO, Yang A, Bielik H, Bitzen A, Lüderitz B, Lewalter T. Europace. 2006 Jun;8(6):403-7. Epub 2006 May 10.
"Torsade de pointes" in patients with structural heart disease and atrial fibrillation treated with amiodarone, beta-blockers, and digitalis. Schrickel JW, Schwab JO, Yang A, Bitzen A, Lüderitz B, Lewalter T. Pacing Clin Electrophysiol. 2006 Apr;29(4):363-6.
New insights into the initiation of atrial fibrillation: a detailed intraindividual and interindividual analysis of the spontaneous onset of atrial fibrillation using new diagnostic pacemaker features. Hoffmann E, Sulke N, Edvardsson N, Ruiter J, Lewalter T, Capucci A, Schuchert A, Janko S, Camm J; Atrial Fibrillation Therapy Trial Investigators. Circulation. 2006 Apr 25;113(16):1933-41.
Do we need pacemakers resistant to magnetic resonance imaging? Naehle CP, Litt H, Lewalter T, Sommer T. Europace. 2006 May;8(5):388; author reply 389. No abstract available.
Transient ST-segment-elevation during pulmonary vein ablation using circumferential coiled microelectrodes in a prospective multi-centre study. Risius T, Lewalter T, Lüderitz B, Schwab JO, Spitzer S, Schmitt C, Vester E, Rostock T, Meinertz T, Willems S. Europace. 2006 Mar;8(3):178-81. Epub 2006 Jan 5.
Connexin30.2 containing gap junction channels decelerate impulse propagation through the atrioventricular node. Kreuzberg MM, Schrickel JW, Ghanem A, Kim JS, Degen J, Janssen-Bienhold U, Lewalter T, Tiemann K, Willecke K. Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5959-64. Epub 2006 Mar 29.
Individualized selection of pacing algorithms for the prevention of recurrent atrial fibrillation: Results from the VIP registry. Lewalter T, Yang A, Pfeiffer D, Ruiter J, Schnitzler G, Markert T, Asklund M, Przibille O, Welz A, Esmailzadeh B, Linhart M, Lüderitz B. Pacing Clin Electrophysiol. 2006 Feb;29(2):124-34.
Strategy for safe performance of magnetic resonance imaging on a patient with implantable cardioverter defibrillator. Naehle CP, Sommer T, Meyer C, Strach K, Kreuz J, Litt H, Lewalter T, Schild H, Schwab JO. Pacing Clin Electrophysiol. 2006 Jan;29(1):113-6.
Cerebral diffusion-weighted magnetic resonance imaging: a tool to monitor the thrombogenicity of left atrial catheter ablation. Lickfett L, Hackenbroch M, Lewalter T, Selbach S, Schwab JO, Yang A, Balta O, Schrickel J, Bitzen A, Lüderitz B, Sommer T. J Cardiovasc Electrophysiol. 2006 Jan;17(1):1-7.
[Pharmacotherapy of supraventricular arrhythmias. What comes, what remains, what goes?]. Lewalter T, Nickenig G. Internist (Berl). 2006 Jan;47(1):80-8. Review. German.
[Cardiac pacing for the prevention of atrial fibrillation. A current review]. Yang A, Bitzen A, Schwab JO, Schrickel J, Lüderitz B, Lewalter T. Herz. 2005 Dec;30(8):733-42. Review. German.
Pharmacological and ablative hybrid therapy of atrial fibrillation. Long-term effect on quality of life and arrhythmia-related symptoms. Bielik H, Schrickel J, Shlevkov N, Yang A, Schwab JO, Bitzen A, Lüderitz B, Lewalter T. Z Kardiol. 2005 Sep;94(9):564-9.
[Cardioversion despite pregnancy?]. Lewalter T, Linhart M, Lüderitz B. Dtsch Med Wochenschr. 2005 Aug 26;130(34-35):1974. German. No abstract available.
Gold-tip electrodes--a new "deep lesion" technology for catheter ablation? In vitro comparison of a gold alloy versus platinum-iridium tip electrode ablation catheter. Lewalter T, Bitzen A, Wurtz S, Blum R, Schlodder K, Yang A, Lickfett L, Schwab JO, Schrickel JW, Tiemann K, Linhart M, Zima E, Merkely B, Lüderitz B. J Cardiovasc Electrophysiol. 2005 Jul;16(7):770-2.
Influence of obstructive sleep apnea on heart rate turbulence. Yang A, Schäfer H, Manka R, Andrié R, Schwab JO, Lewalter T, Lüderitz B, Tasci S. Basic Res Cardiol. 2005 Sep;100(5):439-45. Epub 2005 Jun 10.
[Atrial fibrillation -- interventional therapy with respect to age]. Lewalter T, Lüderitz B. Dtsch Med Wochenschr. 2005 Mar 24;130(12):721-5. Review. German
Atrial fibrillation: profit from cardiac pacing? Yang A, Lüderitz B, Lewalter T.Z Kardiol. 2005 Mar;94(3):141-51. Review.
Impact of age and basic heart rate on heart rate turbulence in healthy persons. Schwab JO, Eichner G, Shlevkov N, Schrickel J, Yang A, Balta O, Lewalter T, Lüderitz B. Pacing Clin Electrophysiol. 2005 Jan;28 Suppl 1:S198-201.
Atrial fibrillation: mortality, morbidity, and money; is that all? Importance and variability of burden measurement. Lewalter T, Lüderitz B. Eur Heart J. 2005 Jan;26(2):110-1. Epub 2004 Dec 7. No abstract available.
Influence of basic heart rate and sex on heart rate turbulence in healthy subjects. Schwab JO, Eichner G, Veit G, Schmitt H, Lewalter T, Lüderitz B. Pacing Clin Electrophysiol. 2004 Dec;27(12):1625-31.
Defective epidermal barrier in neonatal mice lacking the C-terminal region of connexin43. Maass K, Ghanem A, Kim JS, Saathoff M, Urschel S, Kirfel G, Grümmer R, Kretz M, Lewalter T, Tiemann K, Winterhager E, Herzog V, Willecke K. Mol Biol Cell. 2004 Oct;15(10):4597-608. Epub 2004 Jul 28.
Characterization of a new pulmonary vein variant using magnetic resonance angiography: incidence, imaging, and interventional implications of the "right top pulmonary vein". Lickfett L, Kato R, Tandri H, Jayam V, Vasamreddy CR, Dickfeld T, Lewalter T, Luderitz B, Berger R, Halperin H, Calkins H. J Cardiovasc Electrophysiol. 2004 May;15(5):538-43.
Mayer-von Rokitansky-Küster-Hauser syndrome in association with a hitherto undescribed variant of the Holt-Oram syndrome with an aorto-pulmonary window. Ulrich U, Schrickel J, Dorn C, Richter O, Lewalter T, Lüderitz B, Rhiem K. Hum Reprod. 2004 May;19(5):1201-3. Epub 2004 Apr 7.
Heart rate variability in patients suffering from structural heart disease and decreased AV-nodal conduction capacity. Insights into the formation of heart rate variability. Schwab JO, Eichner G, Schmitt H, Schrickel J, Yang A, Balta O, Lüderitz B, Lewalter T. Z Kardiol. 2004 Mar;93(3):229-33.
ECG signs mimicking acute inferior wall myocardial infarction are associated with elevated myocardial enzymes during isolation of pulmonary vein for focal atrial fibrillation. Schwab JO, Burkhardt D, Yang A, Schrickel J, Lüderitz B, Lewalter T. Europace. 2004 Mar;6(2):111-5.
Incidence of venous obstruction following insertion of an implantable cardioverter defibrillator. A study of systematic contrast venography on patients presenting for their first elective ICD generator replacement. Lickfett L, Bitzen A, Arepally A, Nasir K, Wolpert C, Jeong KM, Krause U, Schimpf R, Lewalter T, Calkins H, Jung W, Lüderitz B. Europace. 2004 Jan;6(1):25-31.
Influence of the point of origin on heart rate turbulence after stimulated ventricular and atrial premature beats. Schwab JO, Shlevkov N, Grunwald K, Schrickel JW, Yang A, Lickfett L, Lewalter T, Lüderitz B. Basic Res Cardiol. 2004 Jan;99(1):56-60. Epub 2003 Nov 14.
Accessory pathway catheter ablation inside the neck of a coronary sinus diverticulum. Lewalter T, Yang A, Schwab JO, Lüderitz B. J Cardiovasc Electrophysiol. 2003 Dec;14(12):1386. No abstract available.
Amiodarone-associated "torsade de pointes". Relevance of concomitant cardiovascular medication in a patient with atrial fibrillation and structural heart disease. Schrickel J, Bielik H, Yang A, Schwab JO, Shlevkov N, Schimpf R, Lüderitz B, Lewalter T. Z Kardiol. 2003 Oct;92(10):889-92.
Decremental pulmonary venous pulse propagation: impact for catheter ablation in focal atrial fibrillation. Lewalter T, Burkhardt D, Bielik H, Schrickel J, Bitzen A, Shlevkov N, Yang A, Lüderitz B, Schwab JO. J Interv Card Electrophysiol. 2003 Oct;9(2):269-73.
[Atypical resting ecg pattern in a patient with a positive family history of sudden cardiac death]]. Balta O, Held S, Lewalter T, Schwab JO. Internist (Berl). 2003 Sep;44(9):1175-9. German.
Advanced pacemaker diagnostic features in the characterization of atrial fibrillation: impact on preventive pacing algorithms. Yang A, Hochhäusler M, Schrickel J, Bielik H, Shlevkov N, Schimpf R, Schwab JO, Esmailzadeh B, Schneider C, Mellert F, Welz A, Saborowski F, Lüderitz B, Lewalter T; VIP Study Group. Pacing Clin Electrophysiol. 2003 Jan;26(1 Pt 2):310-3.
[Usefulness of new methods in transtelephone electrocardiographic monitoring]. Wehr MH, Schoels W, Lewalter T, Bethge KP, Gonska BD, Brachmann J. Dtsch Med Wochenschr. 2002 Dec 13;127(50):2679-81. German. No abstract available.
Increasing myocardial contraction and blood pressure in C57BL/6 mice during early postnatal development. Tiemann K, Weyer D, Djoufack PC, Ghanem A, Lewalter T, Dreiner U, Meyer R, Grohe C, Fink KB. Am J Physiol Heart Circ Physiol. 2003 Feb;284(2):H464-74. Epub 2002 Oct 31.
Decremental intravenous pulse propagation during extrastimulus pacing: relevance for catheter ablation of focal atrial fibrillation. Lewalter T, Burkhardt D, Chun S, Schimpf R, Bielik H, Schrickell J, Shlevkov N, Yang A, Lüderitz B. Europace. 2002 Oct;4(4):411-5.
[Commercialisation of atrial fibrillation: is atrial fibrillation really so harmful?]. Lewalter T. Dtsch Med Wochenschr. 2002 Oct 11;127(41):2149-50. German. No abstract available.
[Cardiac resynchronization therapy by biventricular pacing. How many patients with left ventricular dysfunction are eligible?]. Yang A, Wolpert C, Schimpf R, Schulz T, Krause U, Jung W, Herwig S, Jeong KM, Omran H, Lewalter T, Lüderitz B. Dtsch Med Wochenschr. 2002 Oct 25;127(43):2259-63. German.
Circumferential pulmonary vein mapping and ablation in focal atrial fibrillation: single catheter technique. Lewalter T, Burkhardt D, Bielik H, Schrickel J, Yang A, Shlevkov N, Schimpf R, Schwab JO, Lüderitz B. J Interv Card Electrophysiol. 2002 Oct;7(2):165-70.
Induction of atrial fibrillation in mice by rapid transesophageal atrial pacing. Schrickel JW, Bielik H, Yang A, Schimpf R, Shlevkov N, Burkhardt D, Meyer R, Grohé C, Fink K, Tiemann K, Lüderitz B, Lewalter T. Basic Res Cardiol. 2002 Nov;97(6):452-60.
[Atrial fibrillation: stimulation and pacemaker therapy]. Lewalter T, Yang A, Bielik H, Schrickel J, Lüderitz B. Herz. 2002 Jun;27(4):345-56. Review. German.
Long-term follow-up of fast pathway radiofrequency ablation in atrioventricular nodal reentrant tachycardia. Lickfett L, Pfeiffer D, Schimpf R, Calkins H, Lüderitz B, Lewalter T. Am J Cardiol. 2002 May 1;89(9):1124-5. No abstract available.
Radiofrequency catheter ablation of an incessant ventricular tachycardia following valve surgery. Lewalter T, Jung W, Preusse CJ, Lickfett L, Wolpert C, Yang A, Welz A, Lüderitz B. Pacing Clin Electrophysiol. 2002 Jan;25(1):105-8.
Prevalence of left atrial chamber and appendage thrombi in patients with atrial flutter and its clinical significance. Schmidt H, von der Recke G, Illien S, Lewalter T, Schimpf R, Wolpert C, Becher H, Lüderitz B, Omran H. J Am Coll Cardiol. 2001 Sep;38(3):778-84.
Interference with cardiac pacemakers by magnetic resonance imaging: are there irreversible changes at 0.5 Tesla? Vahlhaus C, Sommer T, Lewalter T, Schimpf R, Schumacher B, Jung W, Lüderitz B. Pacing Clin Electrophysiol. 2001 Apr;24(4 Pt 1):489-95.
Comparison of spontaneous atrial fibrillation electrogram potentials with the P-wave electrogram amplitude in dual chamber pacing with unipolar atrial sensing. Lewalter T, Schimpf R, Kulik D, Wolpert C, Jung W, Lüderitz B. Europace. 2000 Apr;2(2):136-40.
Quality of life in atrial fibrillation: relevance of the autonomic nervous system. Lewalter T, Lüderitz B. Eur Heart J. 2001 Feb;22(3):196-7. No abstract available.
New missense mutation (G626V) in the predicted selectivity filter of the HERG channel associated with familial long QT syndrome. Jahr S, Lewalter T, Hesch RD, Lüderitz B, Englisch S. Hum Mutat. 2000 Jun;15(6):584. No abstract available.
[Drug therapy of cardiac arrhythmias]. Lewalter T, Lüderitz B. Internist (Berl). 2000 Apr;41 Suppl 1:S22-33. Review. German. No abstract available.
Paroxysmal atrial fibrillation]. Lewalter T, Lüderitz B. Dtsch Med Wochenschr. 2000 Apr 20;125 Suppl 1:S8-9. German. No abstract available.
"Sudden Onset" von Vorhofflimmern: Analyse der atrialen Induktionssequenz bei DDD-Schrittmacherpatienten. Kulik D, Lewalter T, Schimpf R, Ballidis T, Jung W, Lüderitz B. Herzschrittmacherther Elektrophysiol. 2000 Jan;11 Suppl 1:95-6. doi: 10.1007/BF03042545. German. No abstract available.
Clinical experience with implantable atrial and combined atrioventricular defibrillators. Jung W, Wolpert C, Esmailzadeh B, Spehl S, Herwig S, Schumacher B, Lewalter T, Omran H, Schimpf R, Vahlhaus C, Welz A, Lüderitz B. J Interv Card Electrophysiol. 2000 Jan;4 Suppl 1:185-95. Review.
Predictors of success in radiofrequency catheter ablation of atrial flutter. Schumacher B, Wolpert C, Lewalter T, Vahlhaus C, Jung W, Lüderitz B. J Interv Card Electrophysiol. 2000 Jan;4 Suppl 1:121-5.
Transverse conduction capabilities of the crista terminalis in patients with atrial flutter and atrial fibrillation. Schumacher B, Jung W, Schmidt H, Fischenbeck C, Lewalter T, Hagendorff A, Omran H, Wolpert C, Lüderitz B. J Am Coll Cardiol. 1999 Aug;34(2):363-73.
Hemodynamic and cardiorespiratory function following internal atrial defibrillation for chronic atrial fibrillation. Schimpf R, Omran H, Jung W, Schumacher B, Lewalter T, MacCarter D, Rabahieh R, Wolpert C, Lüderitz B. Am J Cardiol. 1999 Jun 15;83(12):1633-7.
Verification of linear lesions using a noncontact multielectrode array catheter versus conventional contact mapping techniques. Schumacher B, Jung W, Lewalter T, Wolpert C, Lüderitz B. J Cardiovasc Electrophysiol. 1999 Jun;10(6):791-8.
Oxygen uptake to work rate relation throughout peak exercise in normal subjects: relevance for rate adaptive pacemaker programming. Lewalter T, Rickli H, MacCarter D, Schwartze P, Schimpf R, Schumacher B, Jung W, Candinas R, Lüderitz B. Pacing Clin Electrophysiol. 1999 May;22(5):769-75.
Radiofrequency ablation of atrial flutter due to administration of class IC antiarrhythmic drugs for atrial fibrillation. Schumacher B, Jung W, Lewalter T, Vahlhaus C, Wolpert C, Lüderitz B. Am J Cardiol. 1999 Mar 1;83(5):710-3.
[MRI diagnosis of right ventricular dysplasia]. Sommer T, Lewalter T, Bierhoff E, Pakos E, von Smekal A, Pauleit D, Hofer U, Lüderitz B, Schild H. Rofo. 1998 Dec;169(6):609-15. German.
[QT syndrome: new diagnostic possibilities]. Lewalter T, Englisch S, Jahr S, Schumacher B, Jung W, Hesch RD, Lüderitz B. Z Kardiol. 1998 Jul;87(7):517-21. Review. German.
Specific considerations with the automatic implantable atrial defibrillator. Jung W, Wolpert C, Esmailzadeh B, Spehl S, Herwig S, Schumacher B, Lewalter T, Omran H, Kirchhoff PG, Lüderitz B. J Cardiovasc Electrophysiol. 1998 Aug;9(8 Suppl):S193-201.
Radiofrequency ablation of atrial flutter. Schumacher B, Lewalter T, Wolpert C, Jung W, Lüderitz B. J Cardiovasc Electrophysiol. 1998 Aug;9(8 Suppl):S139-45. Review.
[Catheter ablation of atrial flutter. A dependable therapeutic procedure]. Schumacher B, Jung W, Lewalter T, Wolpert C, Lüderitz B. Dtsch Med Wochenschr. 1998 May 29;123(22):701-6. Review. German. No abstract available.
Acute and long-term effects of consecutive radiofrequency applications on conduction properties of the subeustachian isthmus in type I atrial flutter. Schumacher B, Pfeiffer D, Tebbenjohanns J, Lewalter T, Jung W, Lüderitz B. J Cardiovasc Electrophysiol. 1998 Feb;9(2):152-63.
[Spiroergometric and echocardiographic studies on hemodynamics in patients after internal atrial defibrillation of chronic atrial fibrillation]. Schimpf R, Omran H, Rabahieh R, Jung W, Lewalter T, Maccarter D, Wolpert C, Lüderitz B. Herzschrittmacherther Elektrophysiol. 1998 Feb;9 Suppl 1:3-4. doi: 10.1007/BF03042417. German. No abstract available.
Oxygen uptake kinetics during low intensity exercise: relevance for rate adaptive pacemaker programming. Lewalter T, Rickli H, MacCarter D, Jung W, Schimpf R, Schwartze P, Candinas R, Lüderitz B. Heart. 1997 Feb;77(2):168-72.
Heart rate to work rate relation throughout peak exercise in normal subjects as a guideline for rate-adaptive pacemaker programming. Lewalter T, MacCarter D, Jung W, Schimpf R, Manz M, Lüderitz B. Am J Cardiol. 1995 Oct 15;76(11):812-6.
The "low intensity treadmill exercise" protocol for appropriate rate adaptive programming of minute ventilation controlled pacemakers. Lewalter T, MacCarter D, Jung W, Bauer T, Schimpf R, Manz M, Lüderitz B. Pacing Clin Electrophysiol. 1995 Jul;18(7):1374-87.
Heart rate during exercise: what is the optimal goal of rate adaptive pacemaker therapy? Lewalter T, Jung W, MacCarter D, Bauer T, Schimpf R, Manz M, Lüderitz B. Am Heart J. 1994 Apr;127(4 Pt 2):1026-30.
Chefarzt-Sekretariat
Frau M. Schmidt
Mo-Fr. 8.00-18.00
089 72400 4391
e-mail
Peter Osypka Herzzentrum
Kliniken Dr. Müller München
Am Isar-Kanal 36
D-81379 München
